PetMed Express, Inc.

Equities

PETS

US7163821066

Drug Retailers

Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
4.22 USD +1.20% Intraday chart for PetMed Express, Inc. -1.40% -44.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (PETS) PETMED EXPRESS Posts Q3 Revenue $65.3M MT
PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
PetMed Express, Inc.(NasdaqGS:PETS) dropped from NASDAQ Internet Index CI
Transcript : PetMed Express, Inc., Q3 2024 Earnings Call, Feb 08, 2024
PetMed Express Names Leslie C. G. Campbell Chairman MT
PetMed Express, Inc. Announces Management Changes CI
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating MT
Petmed Express Insider Bought Shares Worth $301,125, According to a Recent SEC Filing MT
Petmed Express Insider Bought Shares Worth $100,551, According to a Recent SEC Filing MT
Tranche Update on PetMed Express, Inc.'s Equity Buyback Plan announced on August 1, 2011. CI
Traders Eye Fed Meeting for Fresh Cues as US Equity Futures Edge Higher Pre-Bell MT
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating MT
Top Premarket Decliners MT
Transcript : PetMed Express, Inc., Q2 2024 Earnings Call, Oct 30, 2023
Earnings Flash (PETS) PETMED EXPRESS Reports Q2 Revenue $71M, vs. Street Est of $76M MT
PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023 CI
PetMed Express, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Morgan Stanley Adjusts Price Target on PetMed Express to $10 From $17, Maintains Underweight Rating MT
PetMed Express Partners With Pumpkin Insurance to Offer Pet Insurance MT
PetMed Express, Inc Teams Up with Pumpkin® to Help Make Pet Care Simple and Affordable CI
PetMed Express, Inc.(NasdaqGS:PETS) dropped from S&P Retail Select Industry Index CI
Janover Names Bruce Rosenbloom Chief Financial Officer MT
Tranche Update on PetMed Express, Inc.'s Equity Buyback Plan announced on August 1, 2011. CI
Transcript : PetMed Express, Inc., Q1 2024 Earnings Call, Jul 31, 2023
Earnings Flash (PETS) PETMED EXPRESS Posts Q1 Revenue $78.2M, vs. Street Est of $79.9M MT
Chart PetMed Express, Inc.
More charts
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.22 USD
Average target price
7.75 USD
Spread / Average Target
+83.65%
Consensus
  1. Stock Market
  2. Equities
  3. PETS Stock
  4. News PetMed Express, Inc.
  5. Jefferies & Co Adjusts PetMed Express Price Target to $19 From $20, Maintains Hold Rating